Nature Communications (Aug 2022)
Molecular and in vivo studies of a glutamate-class prolyl-endopeptidase for coeliac disease therapy
Abstract
Celiac disease is characterized by intolerance to gluten, a cereal protein. Here, the authors show that neprosin, a glutamate peptidase from the pitcher plant, efficiently cleaves gluten components under physiological conditions in vitro and in the gut of mice.